Ultragenyx Pharmaceutical Inc. (RARE) Revenue 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$673.0MFY2025 · since FY2016: $133,000 → $673.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $673.0M | +20.2% |
| FY2024 | $560.0M | +29.0% |
| FY2023 | $434.0M | +19.5% |
| FY2022 | $363.3M | +3.4% |
| FY2021 | $351.4M | +29.7% |
| FY2020 | $271.0M | +161.3% |
| FY2019 | $103.7M | +101.4% |
| FY2018 | $51.5M | +1871.5% |
| FY2017 | $2.6M | +1863.9% |
| FY2016 | $133,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice